Koya Medical, an Oakland, CA-based healthcare company, raised up to $30M in funding.
The round was led by OrbiMed.
The company intends to use the funds to support its strategic expansion and continued growth.
Led by CEO Andy Doraiswamy, Koya Medical is a transformative healthcare company developing breakthrough treatments for venous diseases and lymphedema and personalized care. An estimated 20 million Americans live with lymphedema, a progressive, incurable condition where a buildup of protein rich fluid causes painful swelling in the arm, leg, and/or other regions of the body. For most, lymphedema requires lifelong maintenance and various levels of therapy to control swelling and pain. Lymphedema can result from a variety of factors, including cancer, chronic venous disease, infection, and surgery.
Commenting on the news, Andy Doraiswamy said: “Lymphedema and chronic venous diseases have tremendous unmet needs where millions of patients suffer due to the progressive nature of these conditions and their debilitating impacts. With OrbiMed joining our journey, we will be able to make a stronger impact in improving patient lives“
FinSMEs
15/11/2023